The Daily Star6d
Denmark’s IFU to invest $12.5m in local pharmacy chain
Denmark's IFU will invest $12.5 million in pharmacy chain AKS Khan Pharmaceuticals for the expansion of the latter's network, targeting to cater to 8 million patients annually within three years.
Renal & Urology News4d
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
Drug is the first and only approved monotherapy for refractory major depressive disorder. (HealthDay News) — The US Food and Drug Administration has approved Spravato (esketamine) CIII nasal ...
Fox 234d
FDA approves Spravato nasal spray as a standalone treatment for depression in adults
Parkside Psychiatric Hospital in Tulsa has an on-site Spravato outpatient clinic that sees over 20 patients per week. According to Parkside, these patients are seen at least twice a week for the ...
AOL4d
FDA-approved nasal spray for severe depression can lead to remission
The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of MDD in those who have not responded to at least two oral antidepressants. Hundreds of ...
WebMD4d
What to Know About the New Nasal Spray for Tough Depression
The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...
TheHealthSite6d
US FDA Approves First Of Its Kind Ketamine-Based Nasal Spray To Treat Depression: Know All About This Drug
According to reports, the FDA approved the Johnson & Johnson drug called Spravato (esketamine) to treat some cases of depression in the 2019 however, this was only allowed as a prescription ...
pharmaphorum4d
J&J builds case for antidepressant Spravato with head-to-head trial
Spravato has been approved since 2019 for TRD, with its label extended the following year as a rescue therapy for adults with major depressive disorder (MDD) who were at risk of self-harm or suicide.
tbsnews6d
IFU of Denmark to invest in AKS Khan Pharmaceuticals
The significant investment from IFU, the Danish Investment Fund for Developing Countries, will support AKPL's vision to increase access to world-class healthcare throughout Bangladesh. Keep updated, ...
Fortune6d
FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as stand-alone treatment
An estimated 21 million American adults suffer from clinical depression. © 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes ...
pharmaphorum6d
FDA approves Janssen’s ketamine-based nasal antidepressant
The FDA has approved Janssen’s antidepressant nasal spray Spravato, making it the first new type of depression treatment to hit the market in 30 years – although its use will be restricted to ...
WION5d
A first of its kind: US FDA-approved nasal spray available for treatment-resistant depression in America
After a review of no less than 31 clinical trials from the last six years, the ScienceAlert report said Spravato can now be used on its own. Johnson & Johnson reported that Spravato treated over ...